|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2005-9-27
|
|
pubmed:abstractText |
Neurotoxicity is a common side effect of platinum/taxane-based therapy of ovarian cancer. We performed a double-blind randomized placebo-controlled trial to evaluate the influence of the cytoprotectant amifostine on the neurotoxicity of first-line therapy of ovarian cancer with paclitaxel/carboplatin with or without epirubicin.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0941-4355
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
797-805
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16025262-Adult,
pubmed-meshheading:16025262-Amifostine,
pubmed-meshheading:16025262-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16025262-Carboplatin,
pubmed-meshheading:16025262-Double-Blind Method,
pubmed-meshheading:16025262-Drug Therapy, Combination,
pubmed-meshheading:16025262-Female,
pubmed-meshheading:16025262-Germany,
pubmed-meshheading:16025262-Humans,
pubmed-meshheading:16025262-Neuroprotective Agents,
pubmed-meshheading:16025262-Neurotoxicity Syndromes,
pubmed-meshheading:16025262-Ovarian Neoplasms,
pubmed-meshheading:16025262-Paclitaxel,
pubmed-meshheading:16025262-Placebos,
pubmed-meshheading:16025262-Radiation-Protective Agents
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Neuroprotection with amifostine in the first-line treatment of advanced ovarian cancer with carboplatin/paclitaxel-based chemotherapy--a double-blind, placebo-controlled, randomized phase II study from the Arbeitsgemeinschaft Gynäkologische Onkologoie (AGO) Ovarian Cancer Study Group.
|
|
pubmed:affiliation |
Klinik für Gynäkologie und Geburtshilfe, Campus Kiel Universitätsklinikum Schleswig-Holstein, Michaelisstrasse 16, 24105 Kiel, Germany. fhilpert@email.uni-kiel.de
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|
